BDNF has a neuroprotective role against the pathogenesis of AD by reducing the expression and the activity of -secretase, thereby inhibiting the amyloidogenic pathway and reducing neurotoxic A formation in transgenic mice (Evans et al., 2011)
People report improvements in many areas, including increased energy levels, better sleep, relief of symptoms of anxiety and depression, stronger cognitive function and memory, and improved digestion
Location: Czech Republic More information: Glutathione molecular structure
Acetylcysteine is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: Chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung) Acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis) Pulmonary complications of cystic fibrosis Tracheostomy care Pulmonary complications associated with surgery Use during anesthesia Post-traumatic chest conditions Atelectasis due to mucous obstruction Diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization) After proper administration of acetylcysteine, an increased volume of liquified bronchial secretions may occur